Search results for " Glucose"

showing 10 items of 566 documents

Risk of progression to diabetes and mortality in older people with prediabetes: The English longitudinal study on ageing

2022

Abstract Aims Prediabetes is used to identify people at increased risk for diabetes. However, the importance of prediabetes in older populations is still poorly explored. Therefore, we aimed to investigate the prevalence of prediabetes, based on either glycated haemoglobin (HbA1c) levels or fasting glucose (FG) levels, or both and the progression of prediabetes to diabetes or to mortality in older participants of the English Longitudinal Study on Ageing. Materials and methods Prediabetes was categorized based on HbA1c levels (5.7%–6.4%) and/or FG levels (5.6–7.0 mmol/L). Information regarding mortality and incident diabetes were recorded during follow-up period of 10 years. Results In 2027 …

Glycated HemoglobinBlood GlucoseMaleAgingGlycated Hemoglobin AdiabetesEnglish Longitudinal Study on Ageing (ELSA)prediabetesGeneral MedicineEnglish Longitudinal Study on Ageing (ELSA); diabetes; older people; prediabetes; Aged; Aging; Blood Glucose; Female; Glycated Hemoglobin A; Humans; Longitudinal Studies; Male; Risk Factors; Prediabetic Stateprediabetes diabetes older people English Longitudinal Study on Ageing (ELSA)older peoplePrediabetic StateRisk FactorsHumansFemaleLongitudinal StudiesGeriatrics and GerontologyResearch PaperAgedAge and Ageing
researchProduct

The diabetic cataract: an unusual presentation in a young subject: case report.

1997

This case report concerns a 14-year-old female patient, whose insulin-dependent diabetes mellitus was displayed by one infrequent complication, the cataract. This is an unusual manifestation in a 14-year-old patient; indeed, there are many findings in experimental animals demonstrating the development of this complication by maintaining blood glucose levels above 12 mM. After surgical therapy, complete vision was recovered, but we think that an earlier diagnosis and therapy of metabolic derangement of diabetes may have avoided this complication.

GlycosuriaBlood Glucosemedicine.medical_specialtyAdolescentEndocrinology Diabetes and MetabolismEye diseaseHypercholesterolemiaCataract ExtractionKetone BodiesCataractEndocrinologyGlycosuriaDiabetes mellitusFemale patientInternal MedicinemedicineHumansHypertriglyceridemiaMetabolic derangementbusiness.industrymedicine.diseaseDiabetic cataractSurgeryDiabetes Mellitus Type 1FemalePresentation (obstetrics)medicine.symptomComplicationbusinessJournal of diabetes and its complications
researchProduct

Pancreatic Extracts for the Treatment of Diabetes (1889-1914): Acomatol.

2019

Background Historical review on the early development of organotherapy for diabetes [pancreatic extracts (PE)] and its relationship with the social and political circumstances. Areas of uncertainty The diagnosis of diabetes relied only in the presence of glycosuria and cardinal symptoms. Blood glucose determinations were not regularly available, requiring large volumes for sampling. Micromethods for glycemia were developed just in the last years of the investigated period. Hypoglycemia remains undiscovered. Isolation and purification of PE were difficult tasks due to the unknown chemical structure of the antidiabetic hormone. Data sources (1) Berliner Medizinhistoriches Museum der Charite (…

GlycosuriaBlood Glucosemedicine.medical_specialtyPancreatic diseasemedicine.medical_treatmentMEDLINEPancreatic Extracts030204 cardiovascular system & hematologyHypoglycemia03 medical and health sciences0302 clinical medicineEndocrinologyDiabetes mellitusmedicineDiabetes MellitusHumansHypoglycemic AgentsPharmacology (medical)030212 general & internal medicinePancreasPharmacologybusiness.industryHistory 19th CenturyGeneral MedicineHistory 20th CenturyOrganotherapymedicine.diseaseEndocrine pharmacologyFamily medicinePancreatectomymedicine.symptombusinessAmerican journal of therapeutics
researchProduct

DEEP EUTECTIC SOLVENTS E LIQUIDI IONICI: SOLVENTI PER LO SVILUPPO DI PROCESSI ECO-COMPATIBILI

2020

L’obiettivo di questi tre anni di Dottorato è stato lo studio e l’utilizzo nuovi solventi di reazione in grado di sostituire i solventi organici classici. In particolare sono stati studiati i Deep Eutectic Solvent (DES) e le miscele di Liquidi Ionici (IL). I DES sono stati utilizzati come solventi per lo studio di reazioni organiche, usate per la formazione di nuovi legami C-C. Nello specifico sono state studiate la reazione di Diels-Alder, e diverse reazioni di coupling C-C catalizzate da Pd. In seguito, i DES sono stati utilizzati per la formazione di nuovi gel supramolecolari, chiamati eutectogel. Questi gel sono stati formati usando come gelator amminoacidi naturali, consentendo quindi …

Green Chemistry Deep Eutectic Solvents Solventi Liquidi Ionici Eutectogel gel supramolecolari Diels-Alder solventi alternativi Reazione di accoppiamento C-C Reazione di Suzuki 5-HMF Biomasse Disidratazione di carboidrati Fruttosio Glucosio Saccarosio Processi Eco-compatibili.Settore CHIM/06 - Chimica OrganicaGreen Chemistry Deep Eutectic Solvents Solvents Ionic Liquids Eutectogel supramolecular gels Diels-Alder alternative solvents Cross Coupling Reaction Suzuki Reaction Sonogashira Reaction Heck Reaction Hiyama Reaction 5-HMF Biomass carbohydrate dehydration Fructose Glucose Saccarose.
researchProduct

Ajūrvēda individualizētā cukura diabēta terapijā

2015

Definējot iekļaušanas un izslēgšanas kritērijus, tika veikts randomizēts divu grupu, placebo un kontroles grupas, prospektīvs pētījums, kurā tika iekļauti 32 pacienti. Pirmās pētījuma grupas pacienti lietoja Ajūrvēdas medikamentus kombinācijā ar konvencionālu ārstēšanu un otrās grupas pacienti lietoja placebo medikamentus kombinācijā ar konvencionālu ārstēšanu. Nepieciešami precīzāki iekļaušanas kritēriji, lai veiktu stratificētu nejaušās izlases pētījumu gan Prakriti, gan Vikriti apakšgrupās. Tas nodrošinātu adekvātu pacientu skaitu abās apakšgrupās, pirms statistiskās analīzes veikšanas. Tika pamatota korelācija starp ĶMI/aptaukošanos un 2.tipa cukura diabētu. Trīs mēnešu laikā glikoze tu…

Hba1cDiabetes MellitusAyurvedaFasting Blood GlucoseMedicīnaBody Mass Index
researchProduct

H2 and value added chemicals from photocatalytic conversion of glucose

2015

Commercial and home prepared bare and Pt-supported TiO2 samples were used as the photocatalysts for the aqueous aerobic and anaerobic photo-conversion of glucose at ambient pressure and temperature. H2 and valuable chemicals were the obtained products. The home prepared samples resulted more active than the commercial ones

Hydrogen photocatalysis glucoseSettore CHIM/07 - Fondamenti Chimici Delle Tecnologie
researchProduct

Plasma Insulin Levels and Hypoglycemia Affect Subcutaneous Interstitial Glucose Concentration

2018

[EN] Background: Continuous glucose monitoring (CGM) accuracy during hypoglycemia is suboptimal. This might be partly explained by insulin or hypoglycemia-induced changes in the plasma interstitial subcutaneous (SC) fluid glucose gradient. The aim of the present study was to assess the role of plasma insulin (PI) and hypoglycemia itself in the plasma and interstitial SC fluid glucose concentration in patients with type 1 diabetes mellitus. Methods: Eleven subjects with type 1 diabetes (age 36.59.1 years, HbA(1c) 7.90.4% [62.8 +/- 2.02mmol/mol]; mean +/- standard deviation) were evaluated under hyperinsulinemic euglycemia and hypoglycemia. Each subject underwent two randomized crossover clam…

Hypoglycemia; Interstitial glucose; Subcutaneous glucose sensing; Endocrinology Diabetes and Metabolism; Endocrinology; Medical Laboratory TechnologyAdultBlood GlucoseMalemedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and Metabolismmedicine.medical_treatment030209 endocrinology & metabolismHypoglycemiaAffect (psychology)03 medical and health sciences0302 clinical medicineEndocrinologySubcutaneous glucose sensingInternal medicineDiabetes mellitusMedicineHumansInsulinskin and connective tissue diseases030304 developmental biology0303 health sciencesbusiness.industryContinuous glucose monitoringInsulinnutritional and metabolic diseasesInterstitial glucoseExtracellular FluidMiddle Agedmedicine.diseaseHypoglycemiaINGENIERIA DE SISTEMAS Y AUTOMATICA3. Good healthDiabetes and MetabolismMedical Laboratory TechnologyEndocrinologyDiabetes Mellitus Type 1GlucoseInterstitial glucoseFemalesense organsPlasma insulinbusiness
researchProduct

Pre-Exercise Blood Glucose Levels Determine the Amount of Orally Administered Carbohydrates during Physical Exercise in Individuals with Type 1 Diabe…

2019

The aim of the study was to assess the amount of orally administered carbohydrates needed to maintain euglycemia during moderate-intensity exercise in individuals with type 1 diabetes. Nine participants with type 1 diabetes (four women, age 32.1 &plusmn

Insulin degludecAdultBlood GlucoseMalemedicine.medical_specialtyinsulintype 1 diabetesmedicine.medical_treatmentcarbohydratesBlood sugar030209 endocrinology & metabolismPhysical exerciselcsh:TX341-641Article03 medical and health sciencesYoung Adult0302 clinical medicineOxygen ConsumptionInternal medicineDiabetes mellitusmedicineDietary CarbohydratesHumansType 1 diabetesNutrition and DieteticsCross-Over Studiesexercisebusiness.industryInsulin030229 sport sciencesmedicine.diseaseCrossover studyHypoglycemiaBicyclingEndocrinologyDiabetes Mellitus Type 1Blood chemistryFemaleeuglycemiabusinesslcsh:Nutrition. Foods and food supplyFood ScienceNutrients
researchProduct

Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.

2017

BACKGROUND Degludec is an ultralong-Acting, once-daily basal insulin that is approved for use in adults, adolescents, and children with diabetes. Previous open-label studies have shown lower day-To-day variability in the glucose-lowering effect and lower rates of hypoglycemia among patients who received degludec than among those who received basal insulin glargine. However, data are lacking on the cardiovascular safety of degludec. METHODS We randomly assigned 7637 patients with type 2 diabetes to receive either insulin degludec (3818 patients) or insulin glargine U100 (3819 patients) once daily between dinner and bedtime in a double-blind, treat-To-Target, event-driven cardiovascular outco…

Insulin degludecBlood GlucoseMalemedicine.medical_treatmentDEVOTE Study GroupInsulin GlargineType 2 diabetesKaplan-Meier Estimate030204 cardiovascular system & hematologylaw.inventiondiabetes ; insulin0302 clinical medicineRandomized controlled triallawCardiovascular DiseaseGLUCOSE CONTROL11 Medical and Health SciencesRISKCOMPLICATIONSOUTCOMESIncidenceGeneral MedicineMiddle AgedInsulin Long-ActingVARIABILITYCardiovascular Diseasesdiabetes mellitusFemaleLife Sciences & BiomedicineHumanmedicine.drugmedicine.medical_specialty030209 endocrinology & metabolismAged; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus Type 2; Double-Blind Method; Female; Humans; Hypoglycemia; Hypoglycemic Agents; Incidence; Insulin Glargine; Insulin Long-Acting; Kaplan-Meier Estimate; Male; Middle Aged; Medicine (all)HypoglycemiaBedtimeArticleEVENTS03 medical and health sciencesHYPOGLYCEMIAMedicine General & InternalDouble-Blind MethodInternal medicineDiabetes mellitusGeneral & Internal MedicinemedicineHumansHypoglycemic AgentsIntensive care medicineMETAANALYSISAgedScience & TechnologyHypoglycemic AgentInsulin glarginebusiness.industryInsulinmedicine.diseaseDiabetes Mellitus Type 2businessBASAL INSULIN
researchProduct

Insulin degludec and insulin glargine 300 U/mL: Which of these two insulins causes less hypoglycemia?

2019

The interesting article by Yamabe et al.1 showed, using continuous glucose monitoring, that insulin degludec (I‐Deg) was associated with a high percentage of time with nocturnal hypoglycemia than with insulin glargine 300 U/mL (I‐G300; P = 0.02). However, we observe that some possible confounding factors might have influenced the results, such as differences in concomitant medications, use of the same titration protocol for both kinds of insulin or differences in glucose levels. This is also a recurrent problem in clinical trials, which sometime produce conflicting results. In fact, the study of Yamabe et al. is partly in agreement with some recently published clinical trials that gave diff…

Insulin degludecBlood Glucosemedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and Metabolismmedicine.medical_treatmentdiabetes insulin clinical trials hypoglicemiaInsulinsInsulin GlargineHypoglycemiaDiseases of the endocrine glands. Clinical endocrinologyInternal medicineDiabetes mellitusInternal MedicinemedicineHumansHypoglycemic AgentsLetters to the EditorLetter to the EditorGlycated HemoglobinInsulin glarginebusiness.industryInsulinBlood Glucose Self-Monitoringnutritional and metabolic diseasesGeneral Medicinemedicine.diseaseRC648-665HypoglycemiaClinical trialInsulin Long-ActingEndocrinologyDiabetes Mellitus Type 2businessmedicine.drug
researchProduct